7 August 2026 After more than 14 years at the US International Trade Commission, the new hire says he was drawn to Mintz for its “continued growth in the life sciences sector”.
27 July 2026 The firm has added partners with expertise in life sciences, technology disputes and trademark strategy, alongside leadership changes at its Hong Kong affiliate.
16 July 2026 A high-profile hire will co-chair the firm's new office, bringing experience across biotech, therapeutics, genomics, diagnostics, and medical devices.
14 July 2026 Kevin Scott will lead the organisation representing in-house counsel in the UK, for companies such as AstraZeneca, Eli Lilly, MSD and Regeneron.
8 July 2026 After almost 20 years at Goodwin, the patent and trade secrets supremo whose clients include Meta, IBM and Novartis, joins his new employer’s Washington, DC office.
7 July 2026 Focusing on technology and life sciences clients, the new San Fran-based Debevoise & Plimpton hire brings both in-house and private practice litigation experience across trade secrets and commercial disputes.
2 July 2026 The firm has appointed two new partners in Basel and Bristol, adding decades of expertise from the pharmaceutical and biotech sectors to its growing life sciences practice.
1 July 2026 A first-chair trial lawyer with two decades in high-stakes patent and trade secret disputes brings experience across medical devices, biologics, and pharmaceuticals, alongside a broader technology-focused practice.
